<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34380764</PMID><DateCompleted><Year>2021</Year><Month>11</Month><Day>23</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1529-2401</ISSN><JournalIssue CitedMedium="Internet"><Volume>41</Volume><Issue>38</Issue><PubDate><Year>2021</Year><Month>Sep</Month><Day>22</Day></PubDate></JournalIssue><Title>The Journal of neuroscience : the official journal of the Society for Neuroscience</Title><ISOAbbreviation>J Neurosci</ISOAbbreviation></Journal><ArticleTitle>C-Boutons and Their Influence on Amyotrophic Lateral Sclerosis Disease Progression.</ArticleTitle><Pagination><StartPage>8088</StartPage><EndPage>8101</EndPage><MedlinePgn>8088-8101</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1523/JNEUROSCI.0660-21.2021</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is an adult-onset neurodegenerative disease with progressive motor neuron death, where patients usually die within 5 years of diagnosis. Previously, we showed that the C-boutons, which are large cholinergic synapses to motor neurons that modulate motor neuron activity, are necessary for behavioral compensation in <i>mSOD1<sup>G93A</sup></i> mice, a mouse model for ALS. We reasoned that, since the C-boutons likely increase the excitability of surviving motor neurons to compensate for motor neuron loss during ALS disease progression, then amplitude modulation through the C-boutons likely increases motor neuron stress and worsens disease progression. By comparing male and female <i>mSOD1<sup>G93A</sup></i> mice to <i>mSOD1<sup>G93A</sup></i> mice with genetically silenced C-boutons [<i>mSOD1<sup>G93A</sup></i> ; <i>Dbx1::cre</i>; <i>ChAT<sup>fl/fl</sup></i> (<i>mSOD1<sup>G93A</sup>/C<sup>off</sup></i> )], we show that the C-boutons do not influence the humane end point of <i>mSOD1<sup>G93A</sup></i> mice; however, our histologic analysis shows that C-bouton silencing significantly improves fast-twitch muscle innervation over time. Using immunohistology, we also show that the C-boutons are active in a task-dependent manner, and that symptomatic <i>mSOD1<sup>G93A</sup></i> mice show significantly higher C-bouton activity than wild-type mice during low-intensity walking. Last, by using behavioral analysis, we provide evidence that C-bouton silencing in combination with swimming is beneficial for the behavioral capabilities of <i>mSOD1<sup>G93A</sup></i> mice. Our observations suggest that manipulating the C-boutons in combination with a modulatory-targeted training program may therefore be beneficial for ALS patients and could result in improved mobility and quality of life.<b>SIGNIFICANCE STATEMENT</b> Despite decades of research on amyotrophic lateral sclerosis (ALS), there have been little improvements in treatments and therapies. We sought to better understand how the activation of C-boutons, which are large cholinergic modulatory synapses on motor neurons, change and affect the disease as it progresses. When these C-boutons are genetically silenced and exercises designed to otherwise activate the C-boutons are frequently performed in ALS model mice, the mice perform better than their untreated counterparts over time. C-bouton-targeted therapies could therefore be beneficial for ALS patients and could result in improved mobility and quality of life.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 the authors.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wells</LastName><ForeName>Tyler L</ForeName><Initials>TL</Initials><Identifier Source="ORCID">0000-0003-0432-4670</Identifier><AffiliationInfo><Affiliation>Atlantic Mobility Action Project, Brain Repair Center, Department of Medical Neuroscience, Dalhousie University, Halifax, Nova Scotia B3H 0A8, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Myles</LastName><ForeName>Jacob R</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Atlantic Mobility Action Project, Brain Repair Center, Department of Medical Neuroscience, Dalhousie University, Halifax, Nova Scotia B3H 0A8, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akay</LastName><ForeName>Turgay</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Atlantic Mobility Action Project, Brain Repair Center, Department of Medical Neuroscience, Dalhousie University, Halifax, Nova Scotia B3H 0A8, Canada turgay.akay@dal.ca.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>08</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Neurosci</MedlineTA><NlmUniqueID>8102140</NlmUniqueID><ISSNLinking>0270-6474</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059329" MajorTopicYN="N">Cholinergic Neurons</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013569" MajorTopicYN="N">Synapses</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">C-boutons</Keyword><Keyword MajorTopicYN="N">Sod1G93A</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">behavior</Keyword><Keyword MajorTopicYN="N">genetics</Keyword><Keyword MajorTopicYN="N">mice</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>3</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>7</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>8</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>8</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>8</Month><Day>12</Day><Hour>5</Hour><Minute>42</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34380764</ArticleId><ArticleId IdType="pmc">PMC8460137</ArticleId><ArticleId IdType="doi">10.1523/JNEUROSCI.0660-21.2021</ArticleId><ArticleId IdType="pii">JNEUROSCI.0660-21.2021</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Akay T (2014) Long-term measurement of muscle denervation and locomotor behavior in individual wild-type and ALS model mice. J Neurophysiol 111:694&#x2013;703. 10.1152/jn.00507.2013</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/jn.00507.2013</ArticleId><ArticleId IdType="pubmed">24174653</ArticleId></ArticleIdList></Reference><Reference><Citation>Bielle F, Griveau A, Narboux-N&#xea;me N, Vigneau S, Sigrist M, Arber S, Wassef M, Pierani A (2005) Multiple origins of Cajal-Retzius cells at the borders of the developing pallium. Nat Neurosci 8:1002&#x2013;1012. 10.1038/nn1511</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn1511</ArticleId><ArticleId IdType="pubmed">16041369</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown GC, Neher JJ (2012) Eaten alive! Cell death by primary phagocytosis: &#x201c;phagoptosis&#x201d;. Trends Biochem Sci 37:325&#x2013;332. 10.1016/j.tibs.2012.05.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tibs.2012.05.002</ArticleId><ArticleId IdType="pubmed">22682109</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu AY, Zhai P, Dal Canto MC, Peters TM, Kwon YW, Prattis SM, Gurney ME (1995) Age-dependent penetrance of disease in a transgenic mouse model of familial amyotrophic lateral sclerosis. Mol Cell Neurosci 6:349&#x2013;362. 10.1006/mcne.1995.1027</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/mcne.1995.1027</ArticleId><ArticleId IdType="pubmed">8846004</ArticleId></ArticleIdList></Reference><Reference><Citation>Cleveland DW, Rothstein JD (2001) From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nat Rev Neurosci 2:806&#x2013;819. 10.1038/35097565</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/35097565</ArticleId><ArticleId IdType="pubmed">11715057</ArticleId></ArticleIdList></Reference><Reference><Citation>Conradi S, Skoglund S (1960) Observations on the ultrastructure and distribution of neuronal and glial elements on the motoneuron surface in the lumbosacral spinal cord of the cat during postnatal development. Acta Physiol Scand 333:5&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">5386538</ArticleId></ArticleIdList></Reference><Reference><Citation>Dukkipati SS, Chihi A, Wang Y, Elbasiouny SM (2017) Experimental design and data analysis issues contribute to inconsistent results of C-bouton changes in amyotrophic lateral sclerosis. eNeuro 4:ENEURO.0281-16.2016. 10.1523/ENEURO.0281-16.2016</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/ENEURO.0281-16.2016</ArticleId><ArticleId IdType="pmc">PMC5241941</ArticleId><ArticleId IdType="pubmed">28101533</ArticleId></ArticleIdList></Reference><Reference><Citation>El Oussini H, Bayer H, Scekic-Zahirovic J, Vercruysse P, Sinniger J, Dirrig-Grosch S, Dieterl&#xe9; S, Echaniz-Laguna A, Larmet Y, M&#xfc;ller K, Weishaupt JH, Thal DR, van Rheenen W, van Eijk K, Lawson R, Monassier L, Maroteaux L, Roumier A, Wong PC, van den Berg LH, et al. . (2016) Serotonin 2B receptor slows disease progression and prevents degeneration of spinal cord mononuclear phagocytes in amyotrophic lateral sclerosis. Acta Neuropathol 131:465&#x2013;480. 10.1007/s00401-016-1534-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-016-1534-4</ArticleId><ArticleId IdType="pubmed">26744351</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer LR, Culver DG, Tennant P, Davis AA, Wang M, Castellano-Sanchez A, Khan J, Polak MA, Glass JD (2004) Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp Neurol 185:232&#x2013;240. 10.1016/j.expneurol.2003.10.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2003.10.004</ArticleId><ArticleId IdType="pubmed">14736504</ArticleId></ArticleIdList></Reference><Reference><Citation>Frey D, Schneider C, Xu L, Borg J, Spooren W, Caroni P (2000) Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases. J Neurosci 20:2534&#x2013;2542.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6772256</ArticleId><ArticleId IdType="pubmed">10729333</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallart-Palau X, Tarabal O, Casanovas A, S&#xe1;bado J, Correa FJ, Hereu M, Piedrafita L, Calder&#xf3; J, Esquerda JE (2014) Neuregulin-1 is concentrated in the postsynaptic subsurface cistern of C-bouton inputs to &#x3b1;-motoneurons and altered during motoneuron diseases. FASEB J 28:3618&#x2013;3632. 10.1096/fj.13-248583</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.13-248583</ArticleId><ArticleId IdType="pubmed">24803543</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon T, Tyreman N, Li S, Putman CT, Hegedus J (2010) Functional over-load saves motor units in the SOD1-G93A transgenic mouse model of amyotrophic lateral sclerosis. Neurobiol Dis 37:412&#x2013;422. 10.1016/j.nbd.2009.10.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2009.10.021</ArticleId><ArticleId IdType="pubmed">19879358</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD, Caliendo J, Hentati A, Kwon YW, Deng HX, Chen W, Zhai P, Sufit RL, Siddique T (1994) Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 264:1772&#x2013;1775. 10.1126/science.8209258</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8209258</ArticleId><ArticleId IdType="pubmed">8209258</ArticleId></ArticleIdList></Reference><Reference><Citation>Hegedus J, Putman CT, Gordon T (2007) Time course of preferential motor unit loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis. Neurobiol Dis 28:154&#x2013;164. 10.1016/j.nbd.2007.07.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2007.07.003</ArticleId><ArticleId IdType="pubmed">17766128</ArticleId></ArticleIdList></Reference><Reference><Citation>Hegedus J, Putman CT, Tyreman N, Gordon T (2008) Preferential motor unit loss in the SOD1 G93A transgenic mouse model of amyotrophic lateral sclerosis. J Physiol 586:3337&#x2013;3351. 10.1113/jphysiol.2007.149286</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jphysiol.2007.149286</ArticleId><ArticleId IdType="pmc">PMC2538809</ArticleId><ArticleId IdType="pubmed">18467368</ArticleId></ArticleIdList></Reference><Reference><Citation>Heiman-Patterson TD, Sher RB, Blankenhorn EA, Alexander G, Deitch JS, Kunst CB, Maragakis N, Cox G (2011) Effect of genetic background on phenotype variability in transgenic mouse models of amyotrophic lateral sclerosis: a window of opportunity in the search for genetic modifiers. Amyotroph Lateral Scler 12:79&#x2013;86. 10.3109/17482968.2010.550626</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2010.550626</ArticleId><ArticleId IdType="pubmed">21241159</ArticleId></ArticleIdList></Reference><Reference><Citation>Herron LR, Miles GB (2012) Gender-specific perturbations in modulatory inputs to motoneurons in a mouse model of amyotrophic lateral sclerosis. Neuroscience 226:313&#x2013;323. 10.1016/j.neuroscience.2012.09.031</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2012.09.031</ArticleId><ArticleId IdType="pubmed">23000617</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang YQ, Sarkar A, Am A, Martin JH (2018) Transneuronal downregulation of the premotor cholinergic system after corticospinal tract loss. J Neurosci 38:8329&#x2013;8344. 10.1523/JNEUROSCI.3410-17.2018</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3410-17.2018</ArticleId><ArticleId IdType="pmc">PMC6158693</ArticleId><ArticleId IdType="pubmed">30049887</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawamura Y, Dyck PJ, Shimono M, Okazaki H, Tateishi J, Doi H (1981) Morphometric comparison of the vulnerability of peripheral motor and sensory neurons in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 40:667&#x2013;675. 10.1097/00005072-198111000-00008</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005072-198111000-00008</ArticleId><ArticleId IdType="pubmed">7299423</ArticleId></ArticleIdList></Reference><Reference><Citation>Konsolaki E, Koropouli E, Tsape E, Pothakos K, Zagoraiou L (2020) Genetic inactivation of cholinergic C bouton output improves motor performance but not survival in a mouse model of amyotrophic lateral sclerosis. Neuroscience 450:71&#x2013;80. 10.1016/j.neuroscience.2020.07.047</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2020.07.047</ArticleId><ArticleId IdType="pubmed">32750380</ArticleId></ArticleIdList></Reference><Reference><Citation>Landoni LM, Myles JR, Wells TL, Mayer WP, Akay T (2019) Cholinergic modulation of motor neurons through the C-boutons are necessary for the locomotor compensation for severe motor neuron loss during amyotrophic lateral sclerosis disease progression. Behav Brain Res 369:111914. 10.1016/j.bbr.2019.111914</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbr.2019.111914</ArticleId><ArticleId IdType="pubmed">31022419</ArticleId></ArticleIdList></Reference><Reference><Citation>Lobsiger CS, Boill&#xe9;e S, Pozniak C, Khan AM, McAlonis-Downes M, Lewcock JW, Cleveland DW (2013) C1q induction and global complement pathway activation do not contribute to ALS toxicity in mutant SOD1 mice. Proc Natl Acad Sci U S A 110:E4385&#x2013;E4392. 10.1073/pnas.1318309110</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1318309110</ArticleId><ArticleId IdType="pmc">PMC3831990</ArticleId><ArticleId IdType="pubmed">24170856</ArticleId></ArticleIdList></Reference><Reference><Citation>Milan L, Courtand G, Cardoit L, Masmejean F, Barri&#xe8;re G, Cazalets JR, Garret M, Bertrand SS (2015) Age-related changes in pre- and postsynaptic partners of the cholinergic C-boutons in wild-type and SOD1G93A lumbar motoneurons. PLoS One 10:E0135525. 10.1371/journal.pone.0135525</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0135525</ArticleId><ArticleId IdType="pmc">PMC4549056</ArticleId><ArticleId IdType="pubmed">26305672</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller RG, Mitchell JD, Moore DH (2012) Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Cochrane Database Syst Rev 3:CD001447.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7055506</ArticleId><ArticleId IdType="pubmed">22419278</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagao M, Misawa H, Kato S, Hirai S (1998) Loss of cholinergic synapses on the spinal motor neurons of amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 57:329&#x2013;333. 10.1097/00005072-199804000-00004</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005072-199804000-00004</ArticleId><ArticleId IdType="pubmed">9600225</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliv&#xe1;n S, Calvo AC, Rando A, Mu&#xf1;oz MJ, Zaragoza P, Osta R (2015) Comparative study of behavioural tests in the SOD1G93A mouse model of amyotrophic lateral sclerosis. Exp Anim 64:147&#x2013;153. 10.1538/expanim.14-0077</Citation><ArticleIdList><ArticleId IdType="doi">10.1538/expanim.14-0077</ArticleId><ArticleId IdType="pmc">PMC4427729</ArticleId><ArticleId IdType="pubmed">25736480</ArticleId></ArticleIdList></Reference><Reference><Citation>Pullen AH, Athanasiou D (2009) Increase in presynaptic territory of C-terminals on lumbar motoneurons of G93A SOD1 mice during disease progression. Eur J Neurosci 29:551&#x2013;555 561. 10.1111/j.1460-9568.2008.06602.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1460-9568.2008.06602.x</ArticleId><ArticleId IdType="pubmed">19187267</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravits J (2014) Focality, stochasticity and neuroanatomic propagation in ALS pathogenesis. Exp Neurol 262:121&#x2013;126. 10.1016/j.expneurol.2014.07.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2014.07.021</ArticleId><ArticleId IdType="pubmed">25108067</ArticleId></ArticleIdList></Reference><Reference><Citation>Robberecht W, Philips T (2013) The changing scene of amyotrophic lateral sclerosis. Nat Rev Neurosci 14:248&#x2013;264. 10.1038/nrn3430</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn3430</ArticleId><ArticleId IdType="pubmed">23463272</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothstein JD (1996) Therapeutic horizons for amyotrophic lateral sclerosis. Curr Opin Neurobiol 6:679&#x2013;687. 10.1016/s0959-4388(96)80103-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0959-4388(96)80103-6</ArticleId><ArticleId IdType="pubmed">8937834</ArticleId></ArticleIdList></Reference><Reference><Citation>Salamatina A, Yang JH, Brenner-Morton S, Bikoff JB, Fang L, Kintner CR, Jessell TM, Sweeney LB (2020) Differential loss of spinal interneurons in a mouse model of ALS. Neuroscience 450:81&#x2013;95. 10.1016/j.neuroscience.2020.08.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2020.08.011</ArticleId><ArticleId IdType="pubmed">32858144</ArticleId></ArticleIdList></Reference><Reference><Citation>Snedecor GW, Cochran WG (1989) Statistical methods, Ed 8. Ames, IA: Iowa State UP.</Citation></Reference><Reference><Citation>Turner BJ, Lopes EC, Cheema SS (2003) The serotonin precursor 5-hydroxytryptophan delays neuromuscular disease in murine familial amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 4:171&#x2013;176. 10.1080/14660820310009389</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14660820310009389</ArticleId><ArticleId IdType="pubmed">14527871</ArticleId></ArticleIdList></Reference><Reference><Citation>Valdez G, Tapia JC, Lichtman JW, Fox MA, Sanes JR (2012) Shared resistance to aging and ALS in neuromuscular junctions of specific muscles. PLoS One 7:e34640. 10.1371/journal.pone.0034640</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0034640</ArticleId><ArticleId IdType="pmc">PMC3317643</ArticleId><ArticleId IdType="pubmed">22485182</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei K, Glaser JI, Deng L, Thompson CK, Stevenson IH, Wang Q, Hornby TG, Heckman CJ, Kording KP (2014) Serotonin affects movement gain control in the spinal cord. J Neurosci 34:12690&#x2013;12700. 10.1523/JNEUROSCI.1855-14.2014</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1855-14.2014</ArticleId><ArticleId IdType="pmc">PMC4166156</ArticleId><ArticleId IdType="pubmed">25232107</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshino H (2019) Edaravone for the treatment of amyotrophic lateral sclerosis. Expert Rev Neurother 19:185&#x2013;193. 10.1080/14737175.2019.1581610</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14737175.2019.1581610</ArticleId><ArticleId IdType="pubmed">30810406</ArticleId></ArticleIdList></Reference><Reference><Citation>Zagoraiou L, Akay T, Martin JF, Brownstone RM, Jessell TM, Miles GB (2009) A cluster of cholinergic premotor interneurons modulates mouse locomotor activity. Neuron 64:645&#x2013;662. 10.1016/j.neuron.2009.10.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2009.10.017</ArticleId><ArticleId IdType="pmc">PMC2891428</ArticleId><ArticleId IdType="pubmed">20005822</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>